From: Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database
 | Overall Survival |  | Disease Specific Survival | |
---|---|---|---|---|
 | HR (95% CI) | P-value | HR (95% CI) | P-value |
Year of diagnosis |  | < 0.001* |  | < 0.001* |
 1988–1992 | Ref |  | Ref |  |
 1993–1997 | 0.89 (0.85–0.93) | < 0.001 | 0.86 (0.82–0.91) | < 0.001 |
 1998–2002 | 0.71 (0.68–0.74) | < 0.001 | 0.68 (0.65–0.71) | < 0.001 |
 2003–2007 | 0.59 (0.56–0.61) | < 0.001 | 0.55 (0.52–0.57) | < 0.001 |
 2008–2012 | 0.52 (0.50–0.54) | < 0.001 | 0.48 (0.46–0.50) | < 0.001 |
 2013–2015 | 0.46 (0.44–0.48) | < 0.001 | 0.42 (0.41–0.44) | < 0.001 |
Age in groups (years) |  | < 0.001* |  | < 0.001* |
 18–44 | Ref |  | Ref |  |
 45–54 | 1.05 (1.00–1.09) | 0.03 | 0.99 (0.95–1.04) | 0.75 |
 55–64 | 1.03 (0.98–1.07) | 0.23 | 0.97 (0.92–1.01) | 0.11 |
 65–74 | 1.19 (1.14–1.24) | < 0.001 | 1.13 (1.08–1.18) | < 0.001 |
  ≥ 75 | 1.60 (1.53–1.67) | < 0.001 | 1.50 (1.44–1.58) | < 0.001 |
Sex | ||||
 Female vs. male | 0.94 (0.92–0.96) | < 0.001 | 0.94 (0.92–0.96) | < 0.001 |
Race | ||||
 White | Ref |  | Ref |  |
 Black | 1.14 (1.12–1.17) | < 0.001 | 1.14 (1.11–1.16) | < 0.001 |
 Other | 0.87 (0.85–0.89) | < 0.001 | 0.87 (0.85–0.89) | < 0.001 |
Ethnicity | ||||
 Hispanic vs. non-Hispanic | 1.00 (0.98–1.02) | 0.88 | 0.98 (0.96–1.00) | 0.10 |
Marital status | ||||
 Married vs. not married | 0.83 (0.82–0.84) | < 0.001 | 0.85 (0.83–0.86) | < 0.001 |
SEER stage |  | < 0.001* |  | < 0.001* |
 Localized | Ref |  | Ref |  |
 Regional | 1.98 (1.95–2.02) | < 0.001 | 2.18 (2,14–2.23) | < 0.001 |
 Distant | 3.58 (3.50–3.66) | < 0.001 | 4.08 (3.98–4.18) | < 0.001 |
Tumor size (cm) |  | < 0.001* |  | < 0.001* |
  ≤ 2 | Ref |  | Ref |  |
 2–5 | 1.56 (1.51–1.61) | < 0.001 | 1.72 (1.65–1.79) | < 0.001 |
  > 5 | 3.10 (3.00–3.20) | < 0.001 | 3.76 (3.62–3.91) | < 0.001 |
Tumor extent |  | < 0.001* |  | < 0.001* |
 Single lesion w/o vascular invasion | Ref |  | Ref |  |
 Multiple lesions w/o vascular invasion | 1.35 (1.31–1.39) | < 0.001 | 1.45 (1.40–1.50) | < 0.001 |
 Lesion(s) w/vascular invasion | 2.11 (2.06–2.15) | < 0.001 | 2.36 (2.31–2.42) | < 0.001 |
Lymph node involvement | Â | Â | Â | Â |
 Yes vs. No | 2.26 (2.19–2.33) | < 0.001 | 2.44 (2.36–2.52) | < 0.001 |
Surgery |  | < 0.001* |  | < 0.001* |
 No surgery performed | Ref |  | Ref |  |
 Liver-directed therapy | 0.38 (0.37–0.39) | < 0.001 | 0.34 (0.33–0.36) | < 0.001 |
 hepatic resection/lobectomy | 0.30 (0.29–0.32) | < 0.001 | 0.29 (0.28–0.30) | < 0.001 |
 Hepatectomy with transplant | 0.14 (0.14–0.15) | < 0.001 | 0.09 (0.09–0.10) | < 0.001 |